Point72 Middle East FZE’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,356
Closed -$607K 859
2023
Q2
$607K Buy
+25,356
New +$607K 0.02% 382